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group (100%, 100%, 100% versus 84%, 72%, 64%
P  .02), and secondary patency at 1, 2, and 3 years for
the reentry device group versus the non reentry device
group (100%, 100%, 100% versus 93%, 91%, 77% P 
.125).
Conclusions: The routine use of reentry devices fur-
ther improves the technical success, safety, and primary
patency of SIA recanalization of iliac artery CTO.
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Objectives: Advances in prosthetic technology have
allowed below knee amputees an efficient and functional
return to their pre-injury level of activity. Below knee
amputation (BKA) can be a more functional option to limb
salvage in select patients. Difficulty remains in patient se-
lection. In order to improve patient selection for limb
salvage versus early BKA, we reviewed our experience with
BKAs and limb salvage to determine predictive variables for
treatment success and ambulation.
Methods: We performed a retrospective, institutional
review board- approved review of below knee amputations
performed by the senior author between 2004 and 2011 in
patients who ambulated pre-operatively.
Results: 286 BKAs on 262 patients. Mean age 59.5
years. 69% were male. Mean follow-up 18.4 months. 4.9%
of the BKAs were performed on patients with traumatic
lower extremity injuries. 86% had diabetes. 25% were on
dialysis. Ambulation rate was 77% after BKA, with 78% and
61% of unilateral and bilateral amputees ambulating, re-
spectively. Pre-amputation variables found to be positively
associated with post-amputation ambulation included fe-
male gender (P  .002). Pre-amputation variables that
approached significance for being negatively associatedwith
post-amputation ambulation included elevated pre-opera-
tive serum creatinine level (P .053). 23% (n67) of BKA
patients required at least one operative revision with most
being due to falls postoperatively.
Conclusions: Following below knee amputation, re-
gardless of etiology, most patients will go on to ambulate
with a prosthesis. Additionally, our review indicated that
women are even more likely to ambulate following a BKA.
Given these successful outcomes following BKA, we believe
BKA should be considered as a viable option for patients in
whom a limb salvage effort will lead to a biomechanically
compromised limb.
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Objectives: To compare the efficacy of PTA/stent and
directional atherectomy for the severely diseased femoro-
popliteal lesions with risk factors shown to decrease
patency.
Methods: All EVT for femoropopliteal lesions from
2005 to 2009 at our institution were reviewed. Patency was
evaluated by Kaplan-Meier analysis.
Results: Of 1776 lesions in our prospective database,
1329 discrete femoropopliteal lesions in 675 patients
(56.4% male, age 72.4) were subjected to analysis. Proce-
dures included: 867 PTA/stent and 375 atherectomy. The
two procedures led to no significant difference in patency of
lesions that have characteristics that predispose interven-
tions to failure (Table): diabetes (P .95), CHF (P .64),
lesions length100mm (P  .07), 80-90% stenosis (P 
.90), or chronic total occlusion (CTO) (P  .34). Further,
using the weighted Disease Severity Score (DSS) shown to
be well correlated with patency (Scored as: diabetes1,
CHF1, length100mm2, 80-90% stenosis2,
CTO3), the primary patency rate of PTA/stent and
atherectomy was not statistically different even for severely
diseased lesions (DSS 6-7) (P  .24).
Conclusions: Both PTA/stent and atherectomy have
equivalent and reasonable primary patency for lesions with
risk factors shown to significantly decrease patency and
canbe used as the first-line modality. Further, our analysis
shows non-inferiority of atherectomy, and therefore a ther-
apeutic option even for lesions considered severely dis-
eased, with the added advantage of eliminating the need for
a foreign body (stent).
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Outpatient Office-Based Endovascular Procedures Are
Safe and Effective: A Five-Year Experience in Over
3000 Cases
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rara1, Todd Reil2, Robert Feldtman1, Joseph Caruso1,
Karen McQuade1. 1DFW Vascular Group, Dallas, TX;
2University Vascular Associates, Los Angeles, CA
Objectives: The endovascular experience in an office-
based angiosuite is different from that in a hospital suite.
The office space has been viewed as unsafe because it lacks
the safety net of immediate hospital resources. This study
looks at the complication rates of 3174 consecutive endo-
vascular cases completed in our office-based angiosuites
between April 2006 and December 2011.
Methods: This experience represents 724 diagnostic
angiograms, 773 angioplasties, 802 angioplasty with
stents, 156 arteriovenous fistula declots, 430 radiofre-
quency ablations, 136 central venous accesses, and 15
coil embolizations. Indications for the procedures were
peripheral vascular disease, chronic venous insufficiency,
end stage renal disease, varicose veins, ulcers, stenosis of
vessels outside the periphery, vertebrobasilar insuffi-
ciency, thrombophlebitis, malfunctioning access, and
thoracic outlet syndrome.
Results: Hypertension was present in 51% of the pa-
tients, while diabetes was present in 28% and coronary
artery disease was present in 24%. 6% of patients were ASA
class IV. The patient population was 57% female and 43%
male (average age of 697.6, range 15-107). We had a
total of 41 complications (1.29%), the most common being
hematoma (15 cases) and device failure (14 cases). We
encountered 1 patient that had to return to the angiosuite.
10 (0.32%) patients required immediate transfer, 11
(0.35%) required semi elective admission for observation
and 4 (0.13%) required emergency surgery. Our low com-
plication rate can be explained by the adoption and utiliza-
tion of the sixth sigma culture of perfection and appropriate
patient selection. The lowest complication rate reported in
the literature from outpatient endovascular procedures is
2.1 %, which is significantly higher than our rate of 1.29%
overall (P  .0135).
Conclusions: These data indicate that the outpatient
office-based setting is a safe and effective environment for a
patient undergoing an endovascular procedure.
Author Disclosures: S. Ahn: Nothing to disclose;
J. Caruso: Nothing to disclose; R. Feldtman: Nothing
to disclose; C. Ferrara: Nothing to disclose; W. Kim:
Nothing to disclose; K. Kollmeyer: Nothing to disclose;
R. Leichter: Nothing to disclose; K. McQuade: Noth-
ing to disclose; T. Reil: Nothing to disclose; M. J.
Uceda: Nothing to disclose; P. Uceda: Nothing to
disclose.
RR10.
Early Quantitative Evaluation of Indocyanine Green
Angiography in Patients with Critical Limb Ischemia
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Objectives: Traditional means of evaluating perfusion
before and after revascularization are often imited by me-
dial calcinosis, open wounds, prior amputations, and infec-
tion. We evaluated the initial application of Indocyanine
Green Angiography (ICGA) and developed quantitative,
reproducible endpoints of perfusion.
Methods: ICGA uses a charge-coupled device camera,
a laser and intravenous contrast to assess skin surface per-
fusion. From Jan to Dec 2011, we performed ICGA within
5 days of 22 revascularization procedures in patients with
Rutherford V and VI ischemia. We also compared ICGA
pre- and post-revascularization in a subset of 9 patients,
including one diabetic who underwent peroneal PTA for an
ischemic heel ulcer (Fig). We evaluated multiple, quantita-
tive methods to assess perfusion.
Results: 17 patients underwent 22 revascularization
procedures (5 open, 17 endo). Ten (45%) healed com-
pletely while 12 (55%) did not (mean follow-up 4.2
months). Paired analysis of ingress (increase in pixel
strength  PxS), ingress rate (slope of increase in PxS),
curve integral (AUC in PxS over time) and egress (decrease
in PxS from maximum) increased significantly (P .05)
after revascularization. Ingress (6038 vs. 4831) and
ingress rate (5.03.9 vs. 3.22.9) trended to be higher in
those who healed.
Conclusions: ICGA provides rapid visual and quanti-
tative information about regional foot perfusion. Further
study is warranted to further define the utility of this
exciting, new technology.
Table. Primary patency
6 months 12 months 24 months
PTA/Stent Atherectomy PTA/stent Atherectomy PTA/stent Atherectomy
DM 78.2 [71.1-83.8] 75.9 [70.8-80.3] 57.3 [49.0-64.8] 58.0 [52.1-63.5] 42.2 [33.8-50.7] 41.8 [35.4-48.1]
CHF 75.9 [64.8-83.9] 70.6 [62.6-77.2] 55.1 [43.1-65.6] 48.9 [39.8-57.4 36.8 [25.3-48.4] 39.6 [30.0-49.0]
Lesion length 100 mm 72.1 [63.0-79.3] 77.4 [72.0-81.8] 49.1 [39.4-58.1] 54.0 [47.6-60.0] 31.8 [22.7-41.3] 38.0 [31.4-44.5]
Lesion 80-90% stenosis 81.1 [73.4-86.7] 79.8 [74.2-84.3] 61.6 [52.6-69.4] 61.7 [54.9-67.8] 46.3 [36.7-55.2] 50.4 [43.1-57.3]
CTO 69.1 [59.6-76.8] 75.7 [68.3-81.6] 53.8 [43.8-62.8] 53.5 [45.0-61.3] 37.5 [27.6-47.4] 35.2 [26.8-43.7]
Severe lesions (DSS 6-7) 79.6 [66.2-88.2] 66.2 [55.9-74.6] 49.4 [34.7-62.6] 41.5 [31.0-51.6] 31.4 [18.2-45.5] 23.5 [14.5-22.7]
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